Endo Axiom
Haymarket
About Endo Axiom
Endo Axiom is an Australian biotechnology firm dedicated on preventing autoimmune illnesses and enhancing the quality of life for diabetics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $698.3K
- Last round: Grant (Jun 2025)
- Website: endoaxiom.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/endo-axiom-62573 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.